15 results · 23ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

LOCKBOX FOR USE WITH CADD SOLIS INFUSION PUMP

FDA 510(k)
FDA Class 2 ·General Hospital

BOSTON SCIENTIFIC SCIMED ATLANTIS CORONARY IMAGING CATHETER, MODEL C4020

FDA 510(k)
FDA Class 2 ·Cardiovascular

PADPRO, MODEL 2502

FDA 510(k)
FDA Class 3 ·Cardiovascular

BD ULTRASAFE X100L PR CLEAR SSL NVS STEIN

FDA Adverse Event
Malfunction ·BECTON DICKINSON·Product code MEG·July 26, 2019

ULTRASAFE X100L PR PLUM SSL NVS STEIN

FDA Adverse Event
Malfunction ·BECTON DICKINSON·Product code MEG·September 26, 2019

ULTRASAFE X100L PR PLUM SSL NVS STEIN

FDA Adverse Event
Malfunction ·BECTON DICKINSON·Product code MEG·August 21, 2019

ULTRASAFE X100L PR PLUM SSL NVS STEIN

FDA Adverse Event
Malfunction ·BECTON DICKINSON·Product code MEG·April 24, 2019

ULTRASAFE X100L PR PLUM SSL NVS STEIN

FDA Adverse Event
Malfunction ·BECTON DICKINSON·Product code MEG·October 3, 2019

ONETOUCHPING GLUCOSEMGMTSYSTEM

FDA Adverse Event
Injury ·ANIMAS CORPORATION·Product code LZG·April 26, 2013

ONETOUCHPING GLUCOSEMGMTSYSTEM

FDA Adverse Event
Malfunction ·ANIMAS CORPORATION·Product code LZG·May 6, 2011

RESTORE RECHARGEABLE NEUROSTIMULATOR

FDA Adverse Event
Injury ·MEDTRONIC PUERTO RICO OPERATIONS CO.·Product code LGW·July 23, 2008

ULTRASAFE X100L PR PLUM SSL NVS STEIN

FDA Adverse Event
Malfunction ·BECTON DICKINSON·Product code MEG·August 23, 2019

ULTRASAFE X100L PR PLUM SSL NVS STEIN

FDA Adverse Event
Malfunction ·BECTON DICKINSON·Product code FMF·March 28, 2019

ULTRASAFE X100L PR GREY SSL SDZ

FDA Adverse Event
Malfunction ·BECTON DICKINSON·Product code MEG·September 11, 2019

CADD-Solis VIP ambulatory Infusion Pumps, Model 2110. Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.

FDA Enforcement
Class I ·Ongoing·Smiths Medical ASD Inc.·August 14, 2024